Trade Names: | |
Synonyms: | |
Status: | Approved (2010) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | AV9U0660CW |
Parent Compound: | ERIBULIN |
InChI Key | QAMYWGZHLCQOOJ-WRNBYXCMSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C41H63NO14S |
Molecular Weight | 826.01 |
AlogP | 3.44 |
Hydrogen Bond Acceptor | 12.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 4.0 |
Polar Surface Area | 146.39 |
Molecular species | BASE |
Aromatic Rings | 0.0 |
Heavy Atoms | 52.0 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Breast Neoplasms | 4 | D001943 | ClinicalTrials |
Breast Neoplasms | 4 | D001943 | ClinicalTrials |
Breast Neoplasms | 4 | D001943 | ClinicalTrials |
Urethral Neoplasms | 3 | D014523 | ClinicalTrials |
Sarcoma | 3 | D012509 | ClinicalTrials |
Salivary Gland Neoplasms | 2 | D012468 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Osteosarcoma | 2 | D012516 | ClinicalTrials |
Head and Neck Neoplasms | 2 | D006258 | ClinicalTrials |
Breast Neoplasms, Male | 2 | D018567 | ClinicalTrials |
Prostatic Neoplasms | 2 | D011471 | ClinicalTrials |
Triple Negative Breast Neoplasms | 2 | D064726 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
Lymphoma | 1 | D008223 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Brain Neoplasms | 0 | D001932 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 70710 |
ChEMBL | CHEMBL1683544 |
FDA SRS | AV9U0660CW |
PubChem | 17755248 |